Surgalign Holdings Inc (SRGA) Inventory Turnover Ratio, from first quarter 2023 to first quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Surgalign Holdings Inc   (NASDAQ: SRGA)
 

Surgalign Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Surgalign Holdings Inc inventory turnover ratio, the Surgalign Holdings Inc 's ability to sell and replace its inventory in the first quarter 2023, sequentially increased to 2.09 in the first quarter 2023, SRGA's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Surgalign Holdings Inc in Mar 31 2023 quarter, has decreased to 175 days, compare to 194 days, in the Dec 31 2022 quarter.

Within Healthcare sector 228 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2023, to 1075, from total ranking in the fourth quarter 2022 at 1544.

SRGA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Surgalign Holdings Inc Market Share?

What is Inventory Turnover Ratio?




SRGA Inventory Turnover Ratio (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Inventory Growth -41.12 % -32.41 % -17.15 % -4.28 % 0.56 %
Y / Y Cost of Sales Growth -5.24 % 146.19 % -19.45 % -11.27 % 2.76 %
Inventory Turnover Ratio (TTM) 2.09 1.88 1.14 1.14 1.16
SRGA's Total Ranking # 1075 # 1544 # 1785 # 1937 # 1868
Average inventory processing period 175 194 319 319 314
Seq. Inventory Growth -23.6 % -22.11 % -10.25 % 10.24 % -12.3 %
Seq. Cost of Sales Growth -74.02 % 326.19 % -14.47 % 0.06 % -32.51 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 95
Healthcare Sector # 229
Overall Market # 1075

Inventory Turnover Ratio Statistics
High Average Low
2.12 1.44 0.85
(Dec 31 2018)   (Dec 31 2017)




Financial Statements
Surgalign Holdings Inc 's Inventories $ 14 Millions Visit SRGA's Balance sheet
Surgalign Holdings Inc 's Cost of Revenues TTM $ 41 Millions Visit SRGA's Income Statement
What are SRGA's Sales? Visit SRGA's Sales by Segment

Other Inventory Turnover Ratios
Surgalign Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SRGA's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SRGA's Competitors
Inventory Turnover Ratio for SRGA's Suppliers
Inventory Turnover Ratio for SRGA's Customers

You may also want to know
SRGA's Sales Growth Rates SRGA's Pe Price to earnings ratio SRGA's Receivables Turnover Ratio SRGA's Stock Quote
SRGA's Net Income Growth Rates SRGA's Ps Price to Sales ratio SRGA's Sales per Employee SRGA's Asset Turnover Ratio
SRGA's Net Margin SRGA's Pb Price to Book ratio SRGA's Financial Strength Ratios SRGA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2023 Inventories at quarter ending Mar 31 2023
Bionexus Gene Lab Corp   8.01 $ 8.983  Millions$ 1  Millions
Cardiff Lexington Corporation  7.97 $ 4.305  Millions$ 1  Millions
Kewaunee Scientific Corporation  7.92 $ 183.906  Millions$ 23  Millions
Kaya Holdings Inc   7.79 $ 0.178  Millions$ 0  Millions
Dmk Pharmaceuticals Corporation  7.58 $ 6.512  Millions$ 1  Millions
National Vision Holdings Inc   7.58 $ 943.602  Millions$ 125  Millions
Star Equity Holdings Inc   7.47 $ 83.998  Millions$ 11  Millions
Societal Cdmo Inc   7.09 $ 70.241  Millions$ 10  Millions
Nutriband Inc   6.90 $ 1.306  Millions$ 0  Millions
Opko Health Inc   6.84 $ 520.405  Millions$ 76  Millions
Novan Inc   6.70 $ 8.458  Millions$ 1  Millions
Collegium Pharmaceutical Inc   6.45 $ 357.740  Millions$ 55  Millions
Inogen Inc   6.18 $ 219.758  Millions$ 36  Millions
Hims and Hers Health Inc   6.12 $ 128.981  Millions$ 21  Millions
Fonar Corporation  6.09 $ 15.402  Millions$ 3  Millions
Patterson Companies Inc   5.85 $ 5,098.526  Millions$ 872  Millions
Nabriva Therapeutics Plc  5.73 $ 29.658  Millions$ 5  Millions
Veracyte Inc   5.53 $ 77.442  Millions$ 14  Millions
Carlisle Companies Incorporated  5.47 $ 4,261.200  Millions$ 779  Millions
Cryoport inc   5.47 $ 139.188  Millions$ 25  Millions
Alimera Sciences Inc  5.32 $ 8.325  Millions$ 2  Millions
Cti Biopharma Corp   5.31 $ 4.460  Millions$ 1  Millions
Avantor Inc   5.27 $ 4,804.600  Millions$ 911  Millions
Adm Tronics Unlimited Inc   5.22 $ 2.019  Millions$ 0  Millions
Ufp Technologies Inc   5.19 $ 278.476  Millions$ 54  Millions
Integer Holdings Corporation  5.10 $ 1,069.765  Millions$ 210  Millions
Exact Sciences Corporation  5.05 $ 596.555  Millions$ 118  Millions
Neptune Wellness Solutions Inc   5.03 $ 45.695  Millions$ 9  Millions
Horizon Therapeutics Public Limited Company  5.02 $ 913.698  Millions$ 182  Millions
Abbvie Inc   4.96 $ 17,348.000  Millions$ 3,495  Millions

Date modified: 2026-08-29T17:40:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.